TP53 and lung adenocarcinoma: NFκB activity was found to increase in p53-null mice and p53 loss triggered activation of NFκB in a mouse model of KrasG12D-driven lung adenocarcinoma while restoring p53 in p53-null lung tumors blocked NFκB and suppressed tumor growth92,101.